AVE avecho biotechnology limited

Hi Tangent. I'm specifically talking of the launch, as that...

  1. 379 Posts.
    Hi Tangent.

    I'm specifically talking of the launch, as that seems to me the only sizeable source of cash flow currently in prospect.

    As to present outflows, the most recent accounts indicated cash was disappearing at about that rate, with only minimal inflows last year. That may well have increased this year, but surely not to an extent to make a huge basic difference.

    I they had to defer OXY, that would surely be a major setback?

    I'm sure they could raise more funds. But so soon, it would signal a major setback in plans, would be on a long term prospectus (OXY $30 million to develop, 2-3 years time, no certainty) & they'd inevitably be screwed big time on price. Major dilution for current shareholders inevitable, I suggest.

    Disappointment, like you, if 'Ferrari' hopes don't work out, but I'd settle for say 300% turn (40c) with a reasonable satisfaction..... And many others would do even better, including some big holdings who might have a few words to say to the Board...
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
-0.001(12.5%)
Mkt cap ! $11.10M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $453 129.4K

Buyers (Bids)

No. Vol. Price($)
40 33486086 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 8328117 7
View Market Depth
Last trade - 13.52pm 04/07/2025 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.